Survival analysis revealed that the BC patients with high HOTAIR/Suv39H1 expression had a significantly worse overall survival than those patients with low/medium HOTAIR/Suv39H1 expression (Fig. 2D). This evidence concerns the gene SUV39H1 and breast cancer.